Progress in Cardiovascular Diseases
Volume 53, Issue 2 , Pages 114-120, September 2010

Why do Kinase Inhibitors Cause Cardiotoxicity and What can be Done About It?

  • Hui Cheng
  • ,
  • Thomas Force

      Affiliations

    • Corresponding Author InformationAddress reprint requests to: Thomas Force, Center for Translational Medicine, Thomas Jefferson University, College Building, Suite 316, 1025 Walnut St., Philadelphia, PA 19107.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Statement of Conflict of Interest: see page 119.

PII: S0033-0620(10)00116-7

doi:10.1016/j.pcad.2010.06.006

Progress in Cardiovascular Diseases
Volume 53, Issue 2 , Pages 114-120, September 2010